These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 23196585)

  • 81. ClC1 chloride channel in myotonic dystrophy type 2 and ClC1 splicing in vitro.
    Ursu SF; Alekov A; Mao NH; Jurkat-Rott K
    Acta Myol; 2012 Oct; 31(2):144-53. PubMed ID: 23097607
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Clinical and genetic analysis of a family with PROMM.
    Grewal RP; Zhang S; Ma W; Rosenberg M; Krahe R
    J Clin Neurosci; 2004 Aug; 11(6):603-5. PubMed ID: 15261229
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Immortalized human myotonic dystrophy muscle cell lines to assess therapeutic compounds.
    Arandel L; Polay Espinoza M; Matloka M; Bazinet A; De Dea Diniz D; Naouar N; Rau F; Jollet A; Edom-Vovard F; Mamchaoui K; Tarnopolsky M; Puymirat J; Battail C; Boland A; Deleuze JF; Mouly V; Klein AF; Furling D
    Dis Model Mech; 2017 Apr; 10(4):487-497. PubMed ID: 28188264
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Neuromyelitis Optica in a Patient from Family with both Myotonic Dystrophy Type 1 and 2.
    Rakocevic-Stojanovic V; Peric S; Dujmovic I; Drulovic J; Pesovic J; Savic-Pavicevic D
    J Neuromuscul Dis; 2017; 4(1):89-92. PubMed ID: 28106565
    [TBL] [Abstract][Full Text] [Related]  

  • 85. [Molecular pathways to myotonic dystrophy].
    Ishiura S
    Nihon Rinsho; 2005 Mar; 63(3):515-21. PubMed ID: 15773354
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Dysautonomia as Onset Symptom of Myotonic Dystrophy Type 2.
    Rossi S; Romano A; Modoni A; Perna F; Rizzo V; Santoro M; Monforte M; Pieroni M; Luigetti M; Pomponi MG; Silvestri G
    Eur Neurol; 2018; 79(3-4):166-170. PubMed ID: 29533949
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Cultured myoblasts from patients affected by myotonic dystrophy type 2 exhibit senescence-related features: ultrastructural evidence.
    Malatesta M; Giagnacovo M; Renna LV; Cardani R; Meola G; Pellicciari C
    Eur J Histochem; 2011; 55(3):e26. PubMed ID: 22073373
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Clinical score for early diagnosis of myotonic dystrophy type 2.
    Ivanovic V; Peric S; Pesovic J; Tubic R; Bozovic I; Petrovic Djordjevic I; Savic-Pavicevic D; Meola G; Rakocevic-Stojanovic V
    Neurol Sci; 2023 Mar; 44(3):1059-1067. PubMed ID: 36401657
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Speech and language abnormalities in myotonic dystrophy: An overview.
    Hanoun S; Sun Y; Ebrahimi F; Ghasemi M
    J Clin Neurosci; 2022 Feb; 96():212-220. PubMed ID: 34789418
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Abnormalities in Skeletal Muscle Myogenesis, Growth, and Regeneration in Myotonic Dystrophy.
    André LM; Ausems CRM; Wansink DG; Wieringa B
    Front Neurol; 2018; 9():368. PubMed ID: 29892259
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Circulating Irisin Is Reduced in Male Patients with Type 1 and Type 2 Myotonic Dystrophies.
    Dozio E; Passeri E; Cardani R; Benedini S; Aresta C; Valaperta R; Corsi Romanelli M; Meola G; Sansone V; Corbetta S
    Front Endocrinol (Lausanne); 2017; 8():320. PubMed ID: 29184538
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Myotonic Muscular Dystrophy Type 2 in CT, USA: A Single-Center Experience With 50 Patients.
    Roy B; Wu Q; Whitaker CH; Felice KJ
    J Clin Neuromuscul Dis; 2021 Mar; 22(3):135-146. PubMed ID: 33595997
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Myotonic dystrophy type 2 in Japan: ancestral origin distinct from Caucasian families.
    Saito T; Amakusa Y; Kimura T; Yahara O; Aizawa H; Ikeda Y; Day JW; Ranum LP; Ohno K; Matsuura T
    Neurogenetics; 2008 Feb; 9(1):61-3. PubMed ID: 18057971
    [TBL] [Abstract][Full Text] [Related]  

  • 94. High disease impact of myotonic dystrophy type 2 on physical and mental functioning.
    Tieleman AA; Jenks KM; Kalkman JS; Borm G; van Engelen BG
    J Neurol; 2011 Oct; 258(10):1820-6. PubMed ID: 21461958
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Hypothyroidism unmasking proximal myotonic myopathy.
    Sansone V; Griggs RC; Moxley RT
    Neuromuscul Disord; 2000 Mar; 10(3):165-72. PubMed ID: 10734262
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Cerebral involvement and related aspects in myotonic dystrophy type 2.
    Peric S; Rakocevic-Stojanovic V; Meola G
    Neuromuscul Disord; 2021 Aug; 31(8):681-694. PubMed ID: 34244019
    [TBL] [Abstract][Full Text] [Related]  

  • 97. New developments in myotonic dystrophies from a multisystemic perspective.
    Montagnese F; Schoser B
    Curr Opin Neurol; 2021 Oct; 34(5):738-747. PubMed ID: 33990102
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Dutch myotonic dystrophy type 2 patients and a North-African DM2 family carry the common European founder haplotype.
    Coenen MJ; Tieleman AA; Schijvenaars MM; Leferink M; Ranum LP; Scheffer H; van Engelen BG
    Eur J Hum Genet; 2011 May; 19(5):567-70. PubMed ID: 21224892
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Prediction of respiratory impairment in myotonic dystrophies using the 'Respiratory involvement symptom checklist' (Respicheck).
    Gutschmidt K; Wirner-Piotrowski C; Angarita NG; Montagnese F; Schoser B; Wenninger S
    Neuromuscul Disord; 2023 Jul; 33(7):610-618. PubMed ID: 37399783
    [TBL] [Abstract][Full Text] [Related]  

  • 100.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.